Vildagliptin

CAS: 665-66-7USP and CEP specifications

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, a...

CAS: 41100-52-1USP and In-house specifications

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health,...

Olpha is one of the leading pharmaceutical manufacturers in chemical and pharmaceutical sector of the Baltic countries with 50 years of experience. Olpha exports solid FDFs, APIs and intermediates to more than 60 countries worldwide.

Olpha has a long-term strategy to expand portfolio and develop sustainable business in European countries and MENA region. Olpha develops, manufactures and distributes FDF products for treatment in Oncology, Neurology, Cardiology and Anti-diabetes therapeutical areas.

Olpha is your knowledgeable companion in the maze of accessible healthcare. We believe that better health is achievable, and with Olpha it is closer than you think!